Classifieds | Archives | Jobs | About TGT | Contact | Subscribe
Last updated 2 minutes ago
Printer Friendly Version | TGT@Twitter | RSS Feed |
3D-printed device could help reduce side effects of chemotherapy
January 12, 2019
 Print    Send to Friend

New York: Researchers have developed a new 3D-printed device that could help reduce side effects of chemotherapy such as hair loss, nausea and heart failure.

Although chemotherapy can kill cancer cells very effectively, healthy cells also get affected.

But if excess chemotherapy drugs could be removed from a patient’s bloodstream after they have worked, they might reduce the side effects.

The new device, developed by researchers from the University of California in the US, absorbs excess drugs before they spread throughout the body.

For example, doxorubicin, a chemotherapy drug, kills more tumour cells when given at higher doses. However, most patients cannot tolerate large amounts of the drug because it can cause heart failure, among other side effects.

But using the device, excess doxorubicin can be filtered out from the blood at locations outside of the tumour to reduce the harmful effects of the drug on the healthy cells.

When doxorubicin was injected into a vein, the drug flowed in the bloodstream to the device, the researchers said.

In the study, published in the journal ACS Central Science, the team used a 3D printer to fabricate tiny cylinders made of poly (ethylene glycol) diacrylate. Inside the cylinders was a square lattice structure that would allow blood cells to pass through it, with a copolymer coating that binds to doxorubicin.

The researchers tested these absorbers in pigs, inserting them into a vein. When they injected doxorubicin into the same vein, the drug flowed in the bloodstream to the device.

By measuring the doxorubicin concentration in the vein at a location after the absorber, the researchers determined that it captured about 64 per cent of the drug from the bloodstream.

The device could open a new route to help patients fight cancer, enabling reduced side effects or an increased chemotherapy dose, the researchers noted.

Indo-Asian News Service

Add this page to your favorite Social Bookmarking websites
Post a comment
Related Stories
UAE Mars Mission in July-Aug next year
DUBAI: The UAE’s Mars Mission will take place between July 14 and Aug.3 in the year 2020, the Mohammed Bin Rashid Space Centre (MBRSC) announced during the MBRSC Science ..
‘Mars soil, rocks similar to UAE’
DUBAI: Dr Christopher Edwards, Member of the Emirates Mars Mission, revealed that robotic probes sent to Mars took clear images of various components of its soil. “We ..
1st gene-edited babies created by China scientist
HONG KONG: A scientist in China claims to have created the world’s first genetically-edited babies, a move that would be a ground-breaking medical first but which has gen..
KhalifaSat launched
KhalifaSat set to make history
ABU DHABI: The first-ever Emirati-designed and made satellite, KhalifaSat, will be launched into space on Monday, Oct 29 2018, marking a breakthrough for the national spa..
Advertise | Copyright